The approach that many practitioners are using for Post SARS CoV2 symptoms are wrong and even dangerous. Using traditional concepts that are associated with the symptoms of Long-Haul Covid19 (LH-Cov). The issue is in addressing the post-viral impact on whole body function. It is not fatigue or any of the other 22 symptoms listed below as per CDC research. Treating these symptoms without addressing the underlying problem(s). This is a post-viral issue and must be dealt with with botanical that treat the post-viral condition(s).
Daniel has done extensive research on treating LH-Cov. Below is some research on the subject but Daniel advises NOT to use ’tonics’ i.e. qi, ‘Blood’, yin or yang stimulating herbs, they may actually worsen the patients symptoms.
Further research will be provided as we do the research and Daniel is constructing a post-viral formulation. Please contact us for any support

Long-Haul SARS-CoV-2
Some patients who have been infected with SARS-CoV-2, the virus that causes COVID-19, have new, recurring, or ongoing symptoms and clinical findings four or more weeks after infection, sometimes after initial symptom recovery. Post-COVID conditions can occur in patients who have had varying degrees of illness during acute infection, including those who had mild or asymptomatic infections. Medical and research communities are still learning about these post-acute symptoms and clinical findings.
Post-COVID conditions are being referred to by a wide range of names, including long COVID, post-acute COVID-19, long-term effects of COVID, post-acute COVID syndrome, chronic COVID, long-haul COVID, late sequelae, and others, as well as the research term post-acute sequalae of SARS-COV-2 infection (PASC).external icon Although standardized case definitions are still being developed, in the broadest sense, post-COVID conditions can be considered a lack of return to a usual state of health following acute COVID-19 illness. Post-COVID conditions might also include development of new or recurrent symptoms that occur after the symptoms of acute illness have resolved.

Post-COVID Conditions
The CDC uses post-COVID conditions as an umbrella term for the wide range of health consequences that are present four or more weeks after infection with SARS-CoV-2. The time frame of four or more weeks provides a rough approximation of effects that occur beyond the acute period, but the timeframe might change as we learn more.
It can be difficult to distinguish symptoms caused by post-COVID conditions from symptoms that occur for other reasons. Patients experiencing the acute and post-acute effects of COVID-19, along with social isolation resulting from COVID-19 pandemic prevention measures, frequently suffer from symptoms of depression, anxiety, or mood changes. Alternative reasons for health problems need to be considered, such as other diagnoses, unmasking of pre-existing health conditions, or even SARS-CoV-2 reinfection. For clinicians considering whether new symptoms could be explained by reinfection, please refer to the CDC guidance on investigating suspected reinfection.
It is also possible that some patients with post-COVID conditions will not have had positive tests for SARS-CoV-2 because of a lack of testing or inaccurate testing during the acute period, or because of waning antibody levels or false-negative antibody testing during follow up.

Multiorgan System Effects of COVID-19
Multiorgan system effects of COVID-19 have been documented in most, if not all, body systems including cardiovascular, pulmonary, renal, dermatologic, neurologic, and psychiatric. Multisystem inflammatory syndrome (MIS) and autoimmune conditions can also occur after COVID-19. MIS can lead to longer term symptoms due to unresolved complications from the illness. The nature and duration of potential post-MIS symptoms are currently under investigation. A wide variety of health effects can persist after the acute illness has resolved (e.g., pulmonary fibrosis, myocarditis). It is unknown how long multiorgan system effects might last and whether or not the effects could lead to chronic health conditions.

Dyspnea or increased respiratory effort
Post-exertional malaise and/or poor endurance
“Brain fog,” or cognitive impairment
Chest pain
Palpitations and/or tachycardia
Abdominal pain
Insomnia and other sleep difficulties
Impaired daily function and mobility
Rash (e.g., urticaria)
Mood changes
Anosmia or dysgeusia
Menstrual cycle irregularities
* Post-exertional malaise (PEM) is the worsening of symptoms following even minor physical or mental exertion, with symptoms typically worsening 12 to 48 hours after activity and lasting for days or even weeks.
Source CDC:

In the mean-time the use of below will bring support according to Mini Rev Med Chem. 2008 Oct;8(11):1106-33.
doi: 10.2174/138955708785909943 and J Drug Target. 2021 Apr;29(4):403-419. doi: 10.1080/1061186X.2020.1853759. 
Anti-Virii, Quercitin, Artemisinin, Baicalin, Lutein, Genistein, Resevetrol and most importantly Chalcones such as Glycyrrhiza glabra, Umbelliferae family, Ferula assa-foetida, Foeniculum vulgare and Angelica Keiskei, known in Japan as Ashitaba (明日葉)